[
    [
        {
            "time": "",
            "original_text": "国盛证券维持长春高新买入评级：业绩符合预期，金赛增长强劲，关注潜在估值修复行情",
            "features": {
                "keywords": [
                    "长春高新",
                    "买入评级",
                    "业绩",
                    "金赛增长",
                    "估值修复"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "国盛证券维持长春高新买入评级：业绩符合预期，金赛增长强劲，关注潜在估值修复行情",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "这些股被盯上了！刘彦春、胡昕炜、清华等知名基金经理最新调研来了！",
            "features": {
                "keywords": [
                    "基金经理",
                    "调研",
                    "刘彦春",
                    "胡昕炜",
                    "张清华"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "这些股被盯上了！刘彦春、胡昕炜、清华等知名基金经理最新调研来了！",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "【山证医药】长春高新（000661.SZ）半年报点评：业绩延续高速增长态势，生长激素持续放量",
            "features": {
                "keywords": [
                    "长春高新",
                    "半年报",
                    "业绩",
                    "高速增长",
                    "生长激素"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【山证医药】长春高新（000661.SZ）半年报点评：业绩延续高速增长态势，生长激素持续放量",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        }
    ]
]